Regeneron Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…
Biotechnology
US, Tarrytown [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of REGN's Analysis
CIK: 872589 CUSIP: 75886F107 ISIN: US75886F1075 LEI: - UEI: -
Secondary Listings
REGN has no secondary listings inside our databases.